Inovio’s Covid Vaccine Trial Slowed on Regulator’s Questions

(Bloomberg) -- Inovio Pharmaceuticals Inc. put a partial hold on a phase 2-3 study of its Covid-19 vaccine after U.S. regulators raised questions about a delivery device used in the inoculation.